Sign In
Buy LEVI
$22.62
-0.240 (-1.05%)
At Close: Jun 03, 2026
Levi Strauss & Co. (NYSE:LEVI) versus Industria de Diseno Textil (OTCMKTS:IDEXY) Head to Head Comparison
01:58am, Monday, 02'nd Mar 2026
Industria de Diseno Textil (OTCMKTS:IDEXY - Get Free Report) and Levi Strauss and Co. (NYSE: LEVI - Get Free Report) are both retail/wholesale companies, but which is the better stock? We will compare
LEVI & KORSINSKY, LLP: CREDIT LOSS RESERVE ADEQUACY CHALLENGED IN PAYSAFE SECURITIES ACTION
09:00am, Wednesday, 25'th Feb 2026
Time-Sensitive: Allegations Focus on Financial Reserve Representations NEW YORK, Feb. 25, 2026 /PRNewswire/ -- PSFE INVESTOR ALERT -- Levi & Korsinsky, LLP alerts investors in Paysafe Limited (NYSE:
LEVI & KORSINSKY, LLP: MEREO BIOPHARMA SECURITIES FILINGS ALLEGEDLY CONTAINED MISLEADING CLINICAL TRIAL DISCLOSURES
09:00am, Wednesday, 25'th Feb 2026
Shareholders Who Purchased During the Class Period Urged to Review Options NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 prohibit maki
LEVI & KORSINSKY, LLP: MANAGEMENT CONFIDENCE REPRESENTATIONS CHALLENGED IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION
09:00am, Wednesday, 25'th Feb 2026
Time-Sensitive: Allegations Focus on Repeated Assurances Regarding Setrusumab Efficacy RARE INVESTOR ALERT "Investors deserve transparency about material risks that could affect their investments," st
LEVI & KORSINSKY, LLP: COMPETITIVE THREAT DISCLOSURES CHALLENGED IN BELLRING BRANDS SECURITIES ACTION
09:00am, Wednesday, 25'th Feb 2026
Time-Sensitive: Allegations Focus on Ready-to-Drink Market Competition Representations NEW YORK, Feb. 25, 2026 /PRNewswire/ -- "Investors deserve transparency about material risks that could affect th
LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN DEFICIENCIES AT VISTAGEN THERAPEUTICS -- CLASS ACTION FILED
09:00am, Wednesday, 25'th Feb 2026
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Shareholder rights firm Levi & Korsinsky, LLP is investigating potential securities law violations by Vistagen Therapeutics, Inc. (NASDAQ: VTGN) and reminds inv
LEVI & KORSINSKY, LLP: MREO Stock Loss Quantifies Investor Damages Following Phase 3 Trial Disclosure
04:00pm, Thursday, 19'th Feb 2026
Critical Information: $2.02 Per Share Loss Quantifies Alleged Investor Damages Critical Information: $2.02 Per Share Loss Quantifies Alleged Investor Damages
NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) securities of the important March 16, 2026 lead plaintiff deadline. THE
LEVI & KORSINSKY, LLP: CHRONOLOGY OF EVENTS IN THE F5, INC. SECURITIES CLASS ACTION
09:00am, Tuesday, 17'th Feb 2026
Key Dates and Disclosure Events Shareholders Need to Know August 9, 2025: Breach allegedly discovered. October 15, 2025: Initial disclosure.
Levi Strauss & Co. (NYSE:LEVI) Given Consensus Recommendation of “Moderate Buy” by Analysts
01:40am, Tuesday, 17'th Feb 2026
Shares of Levi Strauss and Co. (NYSE: LEVI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are presently covering the company, Mar
U.S. Online Prices Post Largest Increase in 12 Years
07:04am, Monday, 16'th Feb 2026
Corporate America's pricing pause may be over, and Levi Strauss (LEVI) is now part of a broader reset that could have direct implications for margins in 2026. A
LEVI & KORSINSKY, LLP: REVENUE GUIDANCE REDUCTION AND CUSTOMER IMPACT CHALLENGES AT ISSUE IN F5, INC. LITIGATION
05:00pm, Thursday, 12'th Feb 2026
Alert: Claims Focus on Alleged Misrepresentations About Operational Challenges Alert: Claims Focus on Alleged Misrepresentations About Operational Challenges
LEVI & KORSINSKY, LLP ANNOUNCES SECURITIES CLASS ACTION FILED AGAINST VISTAGEN THERAPEUTICS UNDER FEDERAL SECURITIES LAWS
09:00am, Wednesday, 11'th Feb 2026
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Vistagen Therapeutics, Inc. (NASDAQ: VTGN). YOU MAY BE AFFECTED IF YOU: Pu
LEVI & KORSINSKY, LLP: PRODUCT SECURITY INTEGRITY CHALLENGED IN F5, INC. SECURITIES ACTION
09:00am, Wednesday, 11'th Feb 2026
Time-Sensitive: Allegations Focus on Source Code Exposure Representations FFIV INVESTOR ALERT "Investors deserve transparency about material risks that could affect their investments," stated Joseph E
Levi Strauss: Expect Demand Momentum To Continue
11:24pm, Monday, 09'th Feb 2026
Levi Strauss remains a buy as DTC and e-commerce channels drive robust, organic growth and brand momentum. Q4 2025 saw organic revenue up 5% y/y, with DTC up 10% and e-commerce surging 22% organically
